Loading
Latest filing published 07 Oct 2016 for Calyx Bio-Ventures Inc., €12k.
No signal scores available.
All filings by Adrian William Bak on record concern Calyx Bio-Ventures Inc. Over a trading history stretching from 12 June 2015 to 7 October 2016, the count stands at 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 7 October 2016: an option exercise of €12k, in Calyx Bio-Ventures Inc. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations